SIGA Technologies Target of Unusually High Options Trading (NASDAQ:SIGA)

SIGA Technologies, Inc. (NASDAQ:SIGA) saw unusually large options trading activity on Wednesday. Traders purchased 1,200 call options on the company. This represents an increase of approximately 1,438% compared to the average daily volume of 78 call options.

SIGA Technologies Price Performance

Shares of NASDAQ SIGA opened at $6.28 on Thursday. The stock’s fifty day moving average price is $6.57 and its two-hundred day moving average price is $7.63. The firm has a market cap of $448.42 million, a price-to-earnings ratio of 5.23 and a beta of 0.94. SIGA Technologies has a one year low of $4.26 and a one year high of $12.83.

SIGA Technologies (NASDAQ:SIGA) last announced its earnings results on Thursday, November 7th. The company reported $0.02 EPS for the quarter. The company had revenue of $10.01 million for the quarter. SIGA Technologies had a net margin of 49.33% and a return on equity of 49.06%. On average, equities analysts anticipate that SIGA Technologies will post 1.04 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Wellington Management Group LLP acquired a new position in shares of SIGA Technologies in the 3rd quarter valued at approximately $757,000. AltraVue Capital LLC lifted its position in shares of SIGA Technologies by 6.6% during the 2nd quarter. AltraVue Capital LLC now owns 2,177,646 shares of the company’s stock worth $16,528,000 after buying an additional 134,450 shares during the last quarter. Hotchkis & Wiley Capital Management LLC lifted its position in shares of SIGA Technologies by 152.6% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 2,048,440 shares of the company’s stock worth $13,827,000 after buying an additional 1,237,620 shares during the last quarter. Harbor Capital Advisors Inc. bought a new position in SIGA Technologies in the third quarter valued at about $1,098,000. Finally, Foundry Partners LLC bought a new position in shares of SIGA Technologies in the third quarter worth about $2,801,000. Institutional investors and hedge funds own 55.40% of the company’s stock.

SIGA Technologies Company Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.